Fat‐Soluble Vitamins in Cystic Fibrosis and Pancreatic Insufficiency
- 1 April 2014
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 58 (4), 443-448
- https://doi.org/10.1097/mpg.0000000000000272
Abstract
Objectives: The aim of the study was to assess the impact of LYM-X-SORB (LXS), an organized lipid matrix that has been shown to be absorbable without pancreatic enzyme therapy on fat-soluble vitamin status in children with cystic fibrosis (CF) and pancreatic insufficiency (PI). Methods: Children with CF and PI were randomized to daily LXS or an isocaloric placebo comparison supplement for 12 months. Serum vitamins A (retinol), D (25-hydroxyvitamin D[25D]), E (α-tocopherol, α-tocopherol:cholesterol ratio), and K (percentage of undercarboxylated osteocalcin [%ucOC] and plasma proteins induced by vitamin K absence factor II [PIVKA II]) were assessed at baseline and 12 months. Dietary intake was determined using 3-day weighed food records and supplemental vitamin intake by a comprehensive questionnaire. Results: A total of 58 subjects (32 boys, age 10.3 ± 2.9 years [mean ± standard deviation]) with complete serum vitamin, dietary and supplemental vitamin data were analyzed. After adjusting for dietary and supplemental vitamin intake, serum retinol increased 3.0 ± 1.4 μg/dL (coefficient ± standard error) (adjusted R2 = 0.02, P = 0.03) and vitamin K status improved as demonstrated by a decreased percentage of undercarboxylated osteocalcin of −6.0% ± 1.6% by 12 months (adjusted R2 = 0.15, P < 0.001). These changes occurred in both the LXS and placebo comparison groups. No changes in serum 25D or α-tocopherol were detected. Both nutrition interventions increased caloric intake a mean of 83 ± 666 kcal/day by 12 months. Conclusions: Vitamins A and K status improved, whereas vitamins D and E status was unchanged during 12 months of LXS and isocaloric placebo comparison supplement in children with CF and PI.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (R44DK060302)
- National Center for Research Resources (UL1RR024134)
- National Center for Advancing Translational Sciences (UL1TR000003)
This publication has 47 references indexed in Scilit:
- Individualized vitamin A supplementation for patients with cystic fibrosisClinical Nutrition, 2013
- Single high-dose oral vitamin D3 (stoss) therapy — A solution to vitamin D deficiency in children with cystic fibrosis?Journal of Cystic Fibrosis, 2013
- Suboptimal vitamin K status despite supplementation in children and young adults with cystic fibrosisThe American Journal of Clinical Nutrition, 2010
- Adulthood Obesity Is Positively Associated with Adipose Tissue Concentrations of Vitamin K and Inversely Associated with Circulating Indicators of Vitamin K Status in Men and WomenJournal of Nutrition, 2010
- Current Treatment Recommendations for Correcting Vitamin D Deficiency in Pediatric Patients with Cystic Fibrosis Are InadequateThe Journal of Pediatrics, 2008
- Vitamin E status in children with cystic fibrosis and pancreatic insufficiencyThe Journal of Pediatrics, 2006
- The effect of vitamin K supplementation on biochemical markers of bone formation in children and adolescents with cystic fibrosisEuropean Journal of Pediatrics, 2006
- Serum vitamin D levels in children with cystic fibrosisPediatric Pulmonology, 2004
- Vitamin K Status and Bone Health: An Analysis of Methods for Determination of Undercarboxylated OsteocalcinJournal of Clinical Endocrinology & Metabolism, 1998
- Serum 25‐hydroxyvitamin D3 is related to physical activity and ethnicity but not obesity in a multicultural workforceAustralian and New Zealand Journal of Medicine, 1995